We are thrilled to be an exhibitor at the ADCES Diabetes Technology Conference (DTC25) in Chicago on December 12 and 13. This unique event focuses on how cutting-edge technology, like Glooko, can empower diabetes care teams and improve outcomes for people with diabetes.

During the show, we’ll share at table #18 how Glooko delivers essential clinical advantages. Attendees will see firsthand how our diabetes management software, compatible with more than 200 diabetes and health monitoring devices and apps, enables care teams to effortlessly analyze patient data, streamline care coordination, and tailor interventions that can lead to improved health outcomes.

Here’s what we’ll showcase at DTC25:

• New Glooko Clinic Dashboard: Designed specifically for busy healthcare providers, the new dashboard in Glooko offers an organized, at-a-glance view of patient trends and crucial clinic metrics. This powerful tool enables care teams to make more informed treatment decisions and build a stronger clinic strategy.
• Seamless EHR Integrations: Glooko streamlines clinical workflows by integrating securely with leading EHR systems. This functionality eliminates the need for healthcare providers to switch platforms, giving care teams a complete, centralized view of all diabetes and related health data within a single, familiar interface, allowing them to work more efficiently.
• EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: Recently acquired by Glooko, EndoTool is the leading patient-specific inpatient insulin-dosing software trusted by 8 of the top 10 U.S. health systems to support safer, more consistent glycemic management at the bedside.

Elevate your practice with our innovative diabetes management platform

Ready to see how Glooko can elevate your clinic? Schedule a meeting with one of our experts at DTC25.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.

At Glooko, we believe that people living with diabetes are the ultimate experts in their own care. This driving principle is the heartbeat of our mission and is deeply woven into our company culture. Nowhere is this more evident than in our diabetes-focused employee resource group (ERG), the Glucose Gladiators. They ensure we live our mission daily by putting the voice of the user at the center of innovation, driving us to improve diabetes care.

Embedding Real-World Diabetes Perspectives into Glooko

Recognizing the critical need to embed real-world experience into our work, a group of employees living with diabetes came together to found the Glucose Gladiators, a vibrant internal community dedicated to connection and support. The ERG is remarkably diverse, including people with Type 1 and 2 diabetes, caregivers, former nurses and healthcare providers, and women who experienced gestational diabetes. Their firsthand perspectives are our greatest asset. By sharing their personal experiences, Glooko is better equipped as a company to create a diabetes management solution that truly resonates and fulfills our core mission.

The ERG’s purpose is to:

• Educate other employees at Glooko about the realities of life with diabetes.
• Foster cross-department collaboration that drives meaningful impact in diabetes care.
• Help evolve our diabetes management platform to better serve the real-world needs of our users. By sharing their personal insights with our product team, we ensure our platform truly makes a difference.

Inside Look at the Glucose Gladiators’ Mission and Initiatives

Want to hear firsthand about the Glucose Gladiators’ impact? Meet Hadley Horton, a Senior Partner Manager at Glooko and a proud member of our ERG. Having lived with Type 1 diabetes since 2009, Hadley shares how the group’s personal experiences fuel their passion for improving the lives of others in the diabetes community.

MKT-0467

Healthcare providers struggle to manage large diabetes populations without a comprehensive view of patient data.

During this webinar, Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, and Glooko Senior Clinical Transformation Director Trisha Martinez, BSN, MBA, RN, explore the new Glooko clinic dashboard, a powerful tool designed to streamline diabetes population health management and enable smarter care across hospitals, health systems, and clinics.

Our clinical experts take a deep dive into this user-friendly dashboard, available in select countries, and showcase its at-a-glance insights into patient trends and key clinic metrics that can help care teams easily interpret complex data for more efficient decision-making.

Ready to optimize diabetes population health management?

Contact Team Glooko for a demo of our new clinic dashboard, which helps healthcare teams manage large diabetes populations more effectively by prioritizing care and boosting patient engagement.

MKT-0468

During this Glooko 101 webinar, Glooko Senior Director of Clinical Transformation Trisha Martinez, BSN, MBA, RN, helps healthcare providers, including endocrinologists, nurses, and certified diabetes care and education specialists, get the most out of their professional Glooko account, reviewing core features and tools that support clinical workflows for both new users and those looking for a refresher.

This session also covers best practices for onboarding patients with diabetes using continuous glucose monitors (CGMs), including how to connect CGM data to Glooko to ensure seamless access to glucose trends and actionable insights from day one.

Time to Optimize your Diabetes Practice

Book a one-on-one session with Team Glooko today to better understand how to optimize Glooko from the start, get customized guidance on connecting CGM data, and gain access to actionable glucose trends care teams need.

MKT-0473

We’re thrilled to share that Glooko will be exhibiting at the 25th Annual Diabetes Technology Meeting (DTM), co-presented by the Diabetes Technology Society (DTS) and the American Diabetes Association, from October 28 to 30 in San Francisco, California.

At the diabetes industry event, we’ll showcase how our cutting-edge digital health platform is transforming care for people living with diabetes and their healthcare providers. Team Glooko is also looking forward to connecting with leading experts and innovators from around the globe as they explore the latest advancements shaping the future of diabetes technology.

Some of the exciting features and happenings that attendees will see at booth #15:

• New Glooko Clinic Dashboard: The dashboard, designed for busy healthcare providers, offers a clear, organized view of patient trends and key clinic metrics based on TIDE metrics developed by Stanford. This new tool helps care teams interpret complex data at-a-glance, allowing them to make more efficient decisions for their patients with diabetes and develop a more effective clinic strategy.
• EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: EndoTool, recently acquired by Glooko, is the only patient-specific insulin dosing system designed to simplify glycemic management in hospitals. Its unique algorithm models each patient’s clinical characteristics and response to insulin, delivering optimal dosing recommendations to reduce the risk of severe hypoglycemia.
• Industry-Leading Device Compatibility: Glooko seamlessly connects to an extensive ecosystem of more than 200 diabetes and health monitoring devices and apps, allowing people with diabetes to sync and share their health data with their care teams to enable better treatment decisions.
• EHR Integrations: Glooko integrates with leading EHR systems to securely centralize diabetes data, eliminating the need for healthcare providers to switch platforms. This innovative functionality allows care teams to work more efficiently using a single interface with a complete view of their patients’ health data.

Expert Insights on the Power of Diabetes Health Data

Don’t miss the Actionable Data presentation given by Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, at 1:30 p.m. PT on October 28. The presentation will offer deep insights into leveraging data to drive better outcomes in diabetes care.

Temple Health to Present New Data on Patient-Specific Subcutaneous Insulin Dosing

A highly anticipated poster,”Safety and Efficacy of a Patient-Specific Inpatient Dosing Application for Subcutaneous Insulin,” will present new evidence from Temple University Health System and Lewis Katz School of Medicine supporting the safety and efficacy of patient-specific insulin dosing for hospitalized patients on subcutaneous insulin. This study highlights outcomes from using the EndoTool SubQ application from Monarch Medical Technologies. The poster will be revealed at 4:30 p.m. PT on October 28.

Enhance Connected Care with Glooko

To find out more about our diabetes management platform from one of our experts at DTM 2025, schedule a meeting.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.

When healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. Available in select countries, the dashboard helps healthcare providers, including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics streamline their diabetes population health management.

Developed for busy healthcare professionals, the new Glooko clinic dashboard is based on TIDE (Timely Interventions for Diabetes Excellence) metrics to help address the challenge of managing a large diabetes patient population. This user-friendly view provides at-a-glance insights into patient population trends and key clinic metrics, making it easier for the entire care team to interpret complex data and guide more efficient decision-making and clinic strategy.

Built on TIDE Metrics for Smarter Diabetes Care

Leveraging evidence-based risk identification logic developed by Stanford researchers to further enhance clinical insights, personalize care, and demonstrate scalable, cost-effective outcomes, the TIDE dashboard, which demonstrated in a 2022 study to reduce screen time for healthcare providers reviewing patient data by 86%, is a powerful tool designed to help clinical teams manage large populations of patients with type 1 diabetes.

The TIDE dashboard uses smart algorithms to analyze and remotely monitor data from continuous glucose monitoring (CGM) devices, helping care teams efficiently and effectively manage their patients’ health. Using essential glucose measures like Time in Range and hypoglycemia, the TIDE model also prioritizes which patients need immediate attention by sorting them by clinical risk, so healthcare providers can focus on those who need it most without sifting through every patient’s data individually.

The TIDE model-based Glooko clinic dashboard offers our professional users a user-friendly way to tackle the challenge of managing a large patient population with three intuitive sections.

Understand Patient Population At-A-Glance

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. This space displays the total number of patients with diabetes, identifies who is actively monitoring their blood glucose by blood glucose monitors (BGM) or CGM, and shows which patients have completed their Glooko account registration and are actively syncing their health data remotely with our connected care platform.

By centralizing these metrics, this comprehensive section of the dashboard helps healthcare providers shape clinic strategy more efficiently and better understand which patients to contact to activate their Glooko account to make more informed decisions based on synced health data.

Prioritize Care Based on Key CGM Metrics

The CGM Patient Risk Stratification section of the new Glooko clinic dashboard helps healthcare providers prioritize patient care and gives care teams a streamlined view of their patient population, sorted by clinical risk based on key glucose metrics from CGMs. Care teams can easily spot which patients need attention first. The dashboard ranks patients using indicators like Time in Range, Time Below Range, and other key CGM indicators, so healthcare providers can prioritize outreach and interventions based on the most important CGM data, making it easier for them to focus their time on the patients who need it most.

Boost Patient Engagement and Optimize Care

The Engagement Metrics module of the new Glooko clinic dashboard helps healthcare providers spot engagement gaps in their patient population over the past 90 days.

The Patient Account Status section examines the patient population to see if they’ve set-up their Glooko account based on Activated, Invited Pending, Never Invited, and Likely Duplicates. With these key metrics, care teams can quickly see which patients with diabetes haven’t completed the sync to Glooko with their diabetes and health monitoring devices as well as the activation process, allowing for more efficient follow-up and activation.

In the Sync Methods section, care teams can see how patients with diabetes are syncing their data with Glooko. When more health data is synced with Glooko from the cloud, Glooko Mobile App, Transmitter, or Uploader, care teams can make more informed and timely treatment decisions.

Experience Glooko’s New Clinic Dashboard

Ready to see how the intuitive, new Glooko clinic dashboard can optimize diabetes population health management at your clinic, hospital, or health system? Contact our team for a demo.

We’re excited to announce the latest updates to Glooko Web 25.2 and Mobile 6.12, which are designed to help healthcare providers and people with diabetes by streamlining workflows, providing a new population management dashboard to triage at-risk patients and review population-level metrics, improving data visualizations, and giving care teams more powerful data from compatible devices to enhance diabetes management.

Introducing the New Clinic Dashboard

In this release, we launched a new clinic dashboard in the U.S. designed to give healthcare professionals at-a-glance insights into population health trends and clinic management metrics. This enhancement makes it easier to interpret complex data and guide decisions and clinic strategy more efficiently across care teams.

Other new clinic dashboard highlights include:

• Population Metrics: This section gives a single, concise, and organized view of the clinic’s total patient population, patients monitoring blood glucose, and those with activated accounts using key engagement and monitoring metrics.
• CGM Patient Risk Stratification: This dashboard, modeled after the Timely Interventions for Diabetes Excellence (TIDE) Dashboard, gives healthcare providers a streamlined view of their patient population, ranked by risk level using key glucose metrics and CGM data only. Care teams can identify risk levels using Time in Range, Time Below Range, and other key CGM indicators to prioritize care.
• Engagement Metrics: This section helps healthcare providers spot engagement gaps within their patient population over the past 90 days and take action to get more patients connected and syncing their devices with Glooko. With more synced health data, care teams can make more informed treatment decisions.

Banner Notification for Missing MRN

Glooko’s connected care platform prioritizes deep EHR integration to bring actionable diabetes data into the systems clinicians already use. To help maintain EHR data integrity and ensure patient matching is seamless, Glooko introduced a clear dismissible banner on the patient dashboard to notify clinicians when a Medical Record Number (MRN) is required but missing.

Tandem Basal Profile Switches

A new icon in DayView and WeekView on the Glooko diabetes management platform identifies when a patient changes their Tandem Personal Profile to give better context for insulin delivery.

GLP-1 Dose Enhancements

GLP-1 doses will now be displayed in the Glooko Web and Mobile software with improved messaging and clinical disclaimers. Healthcare professionals will now receive relevant dose range notifications while also providing precise dose information to support better oversight and patient adherence, while patients will see exact GLP-1 doses up to two decimal places as injected.

Device Type Display in PDFs

Glooko will now display controller device types in the PDF Settings Report, helping clinicians more clearly understand where data originated for users of Omnipod® 5 and other select devices. The report will specifically say on a clear device label the upload method (e.g., Android, iOS, Locked Down Controller) used by the patient.

Updated Insulin Statistics Design

The Glooko Mobile App’s insulin card has been redesigned to enhance clarity and consistency, particularly benefiting users with insulin pump data. This update aims to improve the understanding of insulin averages and minimize confusion between pump and total insulin values by displaying data in one unified insulin card.

More Information on the Latest Glooko Release

For more detailed information about these new features intended to enhance clinical practices and transform diabetes, be sure to check the full release notes on our Glooko Support page.

Glooko is excited to showcase how our connected care platform is transforming diabetes care and simplifying diabetes management at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) in Vienna, Austria, from 15 to 19 September 2025.

At booth C6.07 of the international diabetes conference, Team Glooko will provide partners, industry thought leaders, and healthcare professionals with the opportunity to experience our latest innovations.

• Glooko in Action: We’ll provide live demonstrations of the Glooko Web and Mobile App uniquely designed to address the growing complexities in diabetes care and improve health outcomes of people living with diabetes. With Glooko, healthcare providers can simplify diabetes management, reduce administrative burden, and improve clinical workflows to focus more on delivering care and less on managing data.
• Hedia Diabetes Assistant: Glooko’s recent collaboration with Hedia, a trusted bolus calculator already available in the U.K. and Sweden, enhances precision and efficiency for multiple daily insulin dosing. The new integration offers personalised recommendations and streamlined diabetes management for people living with diabetes while providing healthcare professionals with comprehensive insights through Glooko.
• Industry-Leading Device Compatibility: Through our partnerships, Glooko enables people with diabetes to seamlessly sync and analyze health data from more than 200 diabetes and health monitoring devices. This extensive ecosystem, including CGMs, BGMs, insulin pens and pumps, and health and wellness apps, allows for better collaboration with care teams and improved health outcomes.
• EHR Integrations: Glooko is working to expand its capability to sync with EHR systems across Europe, supporting a smoother flow of data between clinical records and our diabetes software. These integrations are designed to help streamline workflows and reduce administrative tasks, enabling healthcare providers to spend more time focusing on efficient, data-driven patient care.

To meet with one of our experts at EASD 2025, schedule a meeting.

We look forward to seeing you in Vienna!

As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps.

With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other.

Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock.

How Glooko integrates with hybrid closed loop systems

Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes.

The hybrid closed loop systems that currently sync with Glooko include:

• mylife Loop (CamAPS FX and Ypsomed)
• Tandem Control-IQ
• Insulet Omnipod 5
• Dana CamAPS® FX

Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems.

Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries).

Benefits of using hybrid closed loop systems with Glooko

There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including:

• Major changes in treatment that reduce daily burdens and mental stress
• More time with glucose levels in range with less effort
• The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates

There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including:

• An increased monitoring of patients with diabetes who are using closed loop systems
• Strengthening their connection with their patients
• Better management of fluctuations in patients’ glucose levels
• Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses

The future of hybrid closed loop systems

Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life.

As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution.

For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.

At Glooko, we empower certified diabetes care and education specialists (CDCES) by equipping them with the tools needed to help individuals with Type 1, Type 2, gestational diabetes, and prediabetes better manage their condition and reduce the risk of complications.

Our connected care platform offers remote patient monitoring, compatibility with more than 200 diabetes and health monitoring devices, and easy-to-read reports. With EHR integrations to streamline clinical workflows and population health dashboards, CDCES professionals can proactively identify trends, tailor care plans, and help improve health outcomes — making diabetes care and education more efficient, data-driven, and impactful.

If you’re a CDCES planning to attend the Association of Diabetes Care & Education Specialists’ ADCES25 in Phoenix, Team Glooko wants to meet you at booth #1131 to share the latest updates to our innovative diabetes management platform and mobile app and give you the opportunity to see how we’re transforming diabetes care.

Some of the exciting features and happenings that you can expect to see at our booth:

• Ask An Expert: Our booth will host Glooko Senior Director of Clinical Transformation Trisha Martinez, MBA, RN, BSN, an accomplished clinician, who will share best practices for how CDCESs can educate people living with diabetes to use Glooko to better manage their condition. Our resident clinical expert will be on-site to hear feedback, tips, and tricks for using our connected care platform.
  • Friday, August 8: 9:30-10:15 a.m. and 12:15-2:15 p.m.
  • Saturday, August 9: 9-9:45 a.m., 11:45-1 p.m., and 3-4 p.m.
• Glooko Web and Mobile App: We’ll provide live demos of Glooko, our cutting-edge connected care platform designed to simplify diabetes management and make it easier for people with diabetes to input, view, and understand their health data. Mobile app users can also take advantage of the innovative food tracker feature to easily log their food intake and view their food data alongside data from compatible devices, medications, and exercise. Best of all, the synced data can be securely shared with care teams to stay on track between appointments!
• New Clinic Dashboard: This summer, we’ll launch a new clinic dashboard in Glooko that provides a high-level view of a patient population and program performance across key areas. The Population Metrics panel tracks total patients, CGM use, and activation rates — updated every 14 days — to highlight trends and engagement gaps. CGM Risk Stratification uses CGM data to rank patients by clinical risk, helping prioritize care. Engagement Metrics show where patients are in their onboarding journey and how they sync data, enabling staff to focus outreach and improve engagement efforts.
• EHR Integrations: Glooko seamlessly integrates with leading EHR systems to securely consolidate diabetes data in one place, removing the need to switch platforms or manage multiple logins. This feature allows healthcare providers to work more efficiently within a single interface that offers a comprehensive view of each patient’s health data.
• Latest Device Compatibility: Glooko now integrates with Abbott’s FreeStyle Libre CGMs in the U.S., offering real-time glucose and lifestyle data in one platform, empowering people with diabetes to take better control of their health, and enabling healthcare providers to make more informed, data-driven decisions.

To meet with one of our experts at ADCES25, schedule a meeting.

See you in Phoenix!

The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.